Eigengene
Get Full AccessDescription
- Eigengene develops proprietary algorithms and genomic signatures to analyze cancer genomic data, in order to (i) predict an individual patients survival and response to treatment, and (ii) develop drug companion diagnostics. Eigengenes algorithms (i) extend powerful proven methods to do what no others can (namely, simultaneously find similarities and dissimilarities across multiple high-dimensional datasets, known as tensors), and, therefore, (ii) find what others miss (e.g., find in cancer genomic data multi-thousand-marker DNA signatures predictive of a cancer patients outcome). Eigengenes multi-thousand-marker DNA (rather than RNA) signatures offer the highest (i) quality and (ii) reliability of information, and can be (iii) implemented by using existing hardware that is already FDA-approved, and deployed in pathology laboratories.
-
Headquarters: , Palo Alto, California, United States
More -
Phone Number:
-
-
Employees:2
-
Revenue:$0 - 1M
-
Legal Name:Eigengene
-
Eigengene's Social Media
-
Is this data correct?
-
| NAICS Code: 334614 |
Show More
Frequently Asked Questions regarding Eigengene
-
What is Eigengene's Revenue?
Eigengene's revenue is $0 - 1M
-
What is Eigengene's NAICS code?
Eigengene's NAICS code is 334614
-
How many employees are working in Eigengene
Eigengene has 2 employees
-
What is Eigengene's Industry?
Eigengene is in the industry of Computer Software
-
Who is Eigengene's Chief Technology Officer And Co-Founder?
Eigengene's Chief Technology Officer And Co-Founder is Orly Alter

